日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Editorial: Exploring adverse drug reactions: monitoring, mechanism, intervention, and resolution

社论:探讨药物不良反应:监测、机制、干预和解决

Tao, Li; Li, Xin; Wu, Yunhao; Shan, Yunlong

Lycium barbarum Glycopeptide Alleviates Neomycin-Induced Ototoxicity by Inhibiting Tryptophan Hydroxylase-Mediated Serotonin Biosynthesis.

枸杞糖肽通过抑制色氨酸羟化酶介导的血清素生物合成来缓解新霉素引起的耳毒性

Wu Yunhao, Zhang Li, Cao Shengda, Zhang Jingwen, Li Cheng, Shan Yunlong, Liu Qiuping, Yu Zhexiong, Fang Qiaojun, Zhang Yuhua, Fu Xiaolong, So Kwok-Fai, Chai Renjie

Synergistic effects of ferulic acid and wogonin on cholestatic liver injury via gut microbiota modulation

阿魏酸和黄芩苷通过调节肠道菌群对胆汁淤积性肝损伤产生协同作用

Luo, Xin; Mao, Ting; Wang, Xi; Cheng, Peng; Liu, Mingyuan; Tao, Ruizhi; Wang, Feihui; Zhao, Lizhi; Shan, Yunlong; Lu, Yin; Wei, Zhonghong

Pharmacokinetic characteristics of mesenchymal stem cells in translational challenges

间充质干细胞在转化挑战中的药代动力学特征

Shan, Yunlong; Zhang, Mengying; Tao, Enxiang; Wang, Jing; Wei, Ning; Lu, Yi; Liu, Qing; Hao, Kun; Zhou, Fang; Wang, Guangji

Gut Microbiota-Mediated Modulation of Cancer Progression and Therapy Efficacy

肠道菌群介导的癌症进展和治疗效果调节

Cheng, Peng; Shen, Peiliang; Shan, Yunlong; Yang, Yu; Deng, Rui; Chen, Wenxing; Lu, Yin; Wei, Zhonghong

Response to Comment on: Kim et al. Deficiency for Costimulatory Receptor 4-1BB Protects Against Obesity-Induced Inflammation and Metabolic Disorders. Diabetes 2011;60:3159–3168

对以下文章的评论回应:Kim 等人,《共刺激受体 4-1BB 缺乏可预防肥胖引起的炎症和代谢紊乱》,《糖尿病》2011;60:3159–3168

Zhang, Qixiang; Zeng, Zhu; Wei, Ning; Su, Yueyan; Wang, Jing; Ni, Qi; Wang, Yukai; Yang, Jingwen; Liu, Xiaoyan; Xu, Huanke; Wang, Guangji; Shan, Yunlong; Zhou, Fang; Luong, Quyen; Lee, Kevin; Sharma, Rita; Huang, Jun; Yu, Rina